The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
The XFG variant of the severe acute respiratory syndrome coronavirus 2 as continued to spread as the U.S. heads into peak Summer travel season. (Photo by I RYU/VCG via Getty Images) There’s another ...
The new coronavirus variant surging in China has arrived in the US. Here’s what to know about Nimbus
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. A new coronavirus variant is ...
The Nimbus variant, or NB.1.8.1, is a strain of SARS-CoV-2, which causes COVID-19. Alongside the usual symptoms of COVID-19, it can cause a razor blade sensation in the throat and gastrointestinal ...
The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®. The new vaccine is indicated for active immunization to prevent COVID-19 caused by SARS ...
The NB.1.8.1 COVID-19 variant is now the dominant strain in the U.S., exhibiting symptoms similar to previous variants, including a uniquely severe sore throat. The FDA updated warning labels for mRNA ...
COVID-19 viral activity was high in the United States during the first week of September, according to fresh data from the Centers for Disease Control and Prevention. Some regions of the United States ...
Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a common nasal spray could help prevent infection. This randomized ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine New antiviral drugs in development could offer the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results